美股市场个股详情

RCKT Rocket Pharmaceuticals

添加自选
  • 13.247
  • +0.207+1.58%
交易中 11/21 12:53 (美东)
12.08亿总市值-4852市盈率TTM

关于Rocket Pharmaceuticals公司

Rocket Pharmaceuticals Inc 是一家后期生物制药公司。公司专注于开发罕见和毁灭性儿科疾病的基因疗法。公司的渠道产品包括用于Danaon病的RP-A501、用于范可尼贫血的RP-L102、用于白细胞粘附的RP-L201、用于丙酮酸激酶缺乏症的RP-L301和用于婴儿恶性骨质疏松症的RP-L401。

公司介绍

公司代码RCKT
公司名称Rocket Pharmaceuticals
上市日期2015/02/18
发行价格6.00
成立日期1999
CEODr. Gaurav Shah, M.D.
所属市场纳斯达克
员工数量268
年结日12-31
公司地址9 Cedarbrook Drive
城市Cranbury
省份新泽西
国家美国
邮编08512
电话1-609-659-8001

董事高管

  • 姓名
  • 职务
  • 年薪
  • Dr. Gaurav Shah, M.D.
  • Director and Chief Executive Officer
  • 801.36万
  • Martin Wilson, J.D.
  • Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
  • --
  • Mayo Pujols
  • Chief Technical Officer and Executive Vice President
  • 437.77万
  • Raj Prabhakar
  • Chief Business Officer and Senior Vice President
  • --
  • Jonathan Schwartz, M.D.
  • Chief Medical Officer and Chief Gene Therapy Officer
  • 315.78万
  • Dr. Kinnari Patel, M.B.A.,Pharm.D.
  • President, Chief Operating Officer and Head of R&D
  • 484.61万
  • Aaron Ondrey
  • Chief Financial Officer
  • --
  • Mark White
  • General Manager, Commercial Affairs
  • --
  • John Militello, C.P.A.
  • Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
  • 152.76万
  • Dr. Roderick Wong, M.D.
  • Chairman of the Board
  • 41.00万
  • Dr. Mikael Dolsten, M.D.
  • Director
  • --
  • Dr. Naveen Yalamanchi, M.D.
  • Independent Director
  • 41.75万
  • Pedro P. Granadillo
  • Independent Director
  • 43.00万
  • David P. Southwell
  • Independent Director
  • 40.00万
  • Dr. Elisabeth Bjork, M.D.,PhD
  • Independent Director
  • 41.00万
  • Dr. Gotham Makker, M.D.
  • Independent Director
  • 40.00万
  • Robert Keith Woods
  • Independent Director
  • 56.87万
  • Carsten Boess
  • Independent Director
  • 42.75万
  • Dr. Fady Ibraham Malik, M.D.,PhD
  • Independent Director
  • 40.00万

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议
美股
综合热度
股票代码
最新价
涨跌幅

暂无数据